期刊文献+

15-PGDH诱导药物逆转人乳腺癌MCF-7/ADR细胞耐药作用及机制 被引量:5

Reversal Effect and Mechanism of 15-PGHD Induction Drugs on the Multidrug Resistance of Human Breast Cancer Cell Line MCF-7/ADR
原文传递
导出
摘要 目的探讨15-羟前列腺素脱氢酶(15-PGDH)在人乳腺癌多药耐药细胞中的表达,并观察15-PGDH诱导药物对MCF-7/ADR细胞耐药性的影响。方法采用逆转录-聚合酶链反应(RT-PCR)、Western blot检测MCF-7和MCF-7/ADR细胞中15-PGDH、环氧合酶-2(COX-2)mRNA和蛋白表达;ELISA检测细胞上清液中PGE_2含量;四甲基偶氮唑蓝(MTT)法测定15-PGDH诱导药物(吲哚美辛、布洛芬、吡格列酮、地塞米松)对乳腺癌细胞的增殖抑制作用及对多柔比星(adriamycin,ADM)敏感性的影响;Hochest 33258检测细胞凋亡。结果与MCF-7相比,MCF-7/ADR细胞中15-PGDH表达水平明显降低,COX-2表达明显增加,细胞上清液中PGE_2水平显著增加;4种15-PGDH诱导药物可增加MCF-7/ADR细胞15-PGDH表达或同时降低COX-2表达,降低细胞上清液中PGE2含量,增强MCF-7/ADR细胞对ADM的敏感性及诱导细胞凋亡的作用,部分逆转耐药。结论15-PGDH在MCF-7/ADR细胞中低表达,其诱导药物可能通过调控15-PGDH和COX-2影响PGE_2表达,增加化疗药物敏感性、促进细胞凋亡、逆转MCF-7/ADR细胞耐药。 OBJECTIVE To examine the expression of 15-hydroxyprostaglandin dehydrogenase( 15-PGDH) in human multidrugresistant breast cancer line MCF-7/ADR and to explore the reversal effect and mechanism of 15-PGHD induction drugs on MCF-7/ADR cells. METHODS The RT-PCR and Western blot were used to detect 15-PGDH,COX-2 mRNA and protein expression in MCF-7 and MCF-7/ADR cells. PGE_2 levels in supernatant of cells were determined by ELISA assay. Anti-proliferation effect and chemotherapy sensitivity to ADM of 15-PGDH induction drugs( indomethacin,ibuprofen and pioglitazone,dexamethasone) on breast cancer cells were assayed by MTT method. Cell apoptosis was detected by Hochest 33258 stain assay. RESULTS Compared with MCF-7 cells,the 15-PGDH expression was significantly decreased,COX-2 expression was significantly increased and PGE_2 levels in cell supernatant were increased in MCF-7/ADR cells. 15-PGDH induction drugs( indomethacin,ibuprofen and pioglitazone,dexamethasone) increased 15-PGDH expression or both reduced COX-2 expression,and finally reduced PGE_2 levels in MCF-7/ADR cells. Effect of chemosensitivity and apoptosis induction of ADM was enhanced and multidrug resistance was partially reversed when co-treated with 15-PGDH induction drugs. CONCLUSION The expression of 15-PGDH is decreased in human multidrug-resistant breast cancer line MCF-7/ADR. 15-PGDH induction drugs could increase chemosensitivity,promote apoptosis and reverse resistance of MCF-7/ADR cell,the mechanism might related to the influence of PGE2 level by regulated the expression of 15-PGDH and COX-2.
作者 欧阳林旗 王胜峰 魏凤 黄利华 黄娟娟 刘世坤 OUYANG Lin-qi;WANG Sheng-feng;WEI Feng;HUANG Li-hua;HUANG Juan-juan;LIU Shi-kun(Department of Pharmacy,First Affiliated Hospital of Hunan University of Traditional Chinese Medicine,Changsha 410007,China;a.Department of Pharmacy,2b.Medical Center Laboratory,The Third Xiangya Hospital of Central South University,Changsha 410013,China;Department of Pharmacy,The First Hospital of Changsha,Changsha 410005,China)
出处 《中国药学杂志》 CAS CSCD 北大核心 2018年第16期1352-1358,共7页 Chinese Pharmaceutical Journal
关键词 15-羟前列腺素脱氢酶 环氧化酶-2 前列腺素E2 乳腺癌 多药耐药 15-PGDH诱导药物 15-hydroxyprostaglandin dehydrogenase COX-2 PGE2 breast cancer multidrug resistance 15-PGDH inductiondrugs
  • 相关文献

参考文献5

二级参考文献50

  • 1An Gao Xu Shao Guang Li Ji Hong Liu Ai Hua Gan Research Laboratory of Digestive Disease,Huizhou Central People’s Hospital,Huizhou 516001,Guangdong Province,ChinaDr.An Gao Xu graduated from Guangdong Medical College in 1984.He is an associate physician-in-chief,specializing in the research and treatment of gastrointestinal and liver tumors.He has published 24 papers and 1 book..Function of apoptosis and expression of the proteins Bcl-2,p53 and C-myc in the development of gastric cancer[J].World Journal of Gastroenterology,2001,7(3):403-406. 被引量:91
  • 2Xiu-Sheng He Qi Su Zhu-Chu Chen Xiu-Tao He Zhi-Feng Long Hui Ling Liang-Run Zhang Oncology Institute,Nanhua University,Hengyang 421001,Hunan Province,ChinaOncology Institute,Center South University,Changsha 410078,Hunan Province,China Department of Gastroenterology,First People’s Hospital of Changde City,Changde 415003,Hunan Province,China.Expression,deleton and mnutation of ρ16 gene in human gastric cancer[J].World Journal of Gastroenterology,2001,7(4):515-521. 被引量:40
  • 3任先达,吕艳青,叶开和,蔡绍晖,叶春玲.非甾体类抗炎药抗肿瘤作用的分子机制[J].中国药理学通报,2005,21(5):527-531. 被引量:14
  • 4左朝晖,黎祖荣,周晓,欧阳永忠,周征宇,曾亮.环氧合酶-2抑制剂塞来昔布对人肝癌HepG2裸小鼠移植瘤生长和肿瘤血管生成的抑制作用[J].癌症,2006,25(4):414-420. 被引量:25
  • 5Marrogi A J, Travis W D, Welsh J A, et al. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of nonsmall cell lung carcinoma[J]. Clin Cancer Res, 2000, 6(12): 4739-44.
  • 6Kuwano T, Nakao S, Yamamoto H, et al. Cyclooxygenase 2 is a key enzyme for inflammatory cytokineinduced angiogenesis[J]. Faseb J, 2004,18(2): 300-10.
  • 7Glasner A, Avraham R, Rosenne E, et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a betaadrenergic antagonist and a cyclooxygenase2 inhibitor[J].J Immunol, 2010,184(5): 2449-57.
  • 8Shakhar G, BenEliyahu S. In vivo betaadrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats[J].J Immunol, 1998,160(7): 3251-8.
  • 9Reti A, Pap E, Adleff V, et al. Enhanced 5fluorouracil cytotoxicity in high cyclooxygenase2 expressing colorectal cancer cells and xenografts induced by nonsteroidal antiinflammatory drugs via downregulation of dihydropyrimidine dehydrogenase[J]. Cancer Chemother Pharmacol, 2010, 66(2): 219-27.
  • 10Shin Y K, Park J S, Kim H S, et al. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)2 selective inhibitor, via COX2dependent cell cycle regulation on human cancer cells expressing differential COX2 levels[J].Cancer Res, 2005,65(20): 9501-9.

共引文献41

同被引文献29

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部